Skip to main content
Fig. 5 | Genes and Environment

Fig. 5

From: NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer

Fig. 5

Alterations of NCAPD2 gene in pan-cancer. (A) The alteration frequency of NCAPD2 in pan-cancer. (B) The mutation types, sites and case number of NCAPD2 genetic alternation. (C) The survival of patients with NCAPD2 alternation. (D) Correlation between NCAPD2 expression level and ploidy, LOH, MSI, MATH. (E) Intersection analysis of NCAPD2 and ploidy, LOH, MSI, MATH. (F) The correlation between NCAPD2 mRNA expression level and methylation

Back to article page

Genes and Environment

ISSN: 1880-7062

Contact us